SCHEMBL6102452

SCHEMBL6102452

CC(C)c1cc(C(C)C)c(S(=O)(=O)c2ccc(F)cc2)cc1S(=O)(=O)NC1Cc2ccccc2C1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
HTR1A P08908 10/20 0.44
HTR7 P34969 10/20 0.44
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44
APH1B Q8WW43 1/20 0.44
NCSTN Q92542 1/20 0.44
APH1A Q96BI3 1/20 0.44
PSENEN Q9NZ42 1/20 0.44
DRD2 P14416 3/20 0.42
HTR6 P50406 3/20 0.42
HTR2A P28223 3/20 0.41
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
GRM7 Q14831 1/20 0.40
HTR2C P28335 2/20 0.39
KCNH2 Q12809 2/20 0.39
ALOX5AP P20292 1/20 0.39
FEN1 P39748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4638964 0.91 MEN1 (0.45) MEN1KMT2AHTR1AHTR7PSEN1
SCHEMBL4617481 0.85 KDM4E (0.46) KMT2AHTR1AHTR7DRD2HTR6
SCHEMBL6102384 0.82 HTR1A (0.42) KMT2AHTR1AHTR7DRD2HTR6
SCHEMBL4638533 0.78 PSEN1 (0.46) MEN1KMT2AHTR1AHTR7PSEN1
SCHEMBL4619179 0.78 ALDH1A1 (0.47) MEN1KMT2AHTR1AHTR7
SCHEMBL4617920 0.75 HTR1A (0.45) KMT2AHTR1AHTR7DRD2HTR6
SCHEMBL4782205 0.75 CA1 (0.50) MEN1KMT2AHTR1AHTR7PSEN1
SCHEMBL4736402 0.75 HTR1A (0.38) MEN1KMT2AHTR1AHTR7PSEN1
SCHEMBL6101380 0.75 HTR1A (0.41) HTR1AHTR7DRD2HTR6HTR2A
SCHEMBL4617601 0.74 HTR1A (0.44) KMT2AHTR1AHTR7DRD2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 MEN1 886/4885KMT2A 3832/4885HTR1A 3561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.